CRF1 antagonizing astressins (Sentia/Neurocrine Biosciences)

N/A

Report date: 2025/03/19 08:59:03

Base Information

Drug NameCRF1 antagonizing astressins (Sentia/Neurocrine Biosciences)
Drug Alias NameCRF1 antagonizing astressins (Sentia)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCorticotropin-releasing factor receptor 1 antagonists
TargetsCorticotropin-releasing factor receptor 1
Therapy Area/IndicationsAdrenal Hyperplasia, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSentia Medical Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSentia Medical Sciences IncNeurocrine Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAdrenal Hyperplasia, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A